These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34643655)

  • 61. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y; Tian B; Wang Y; Ding H
    Med Sci Monit; 2017 Oct; 23():5096-5105. PubMed ID: 29070784
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.
    Seki N; Toh U; Sayers TJ; Fujii T; Miyagi M; Akagi Y; Kusukawa J; Kage M; Shirouzu K; Yamana H
    Mol Cancer Ther; 2010 Jun; 9(6):1842-51. PubMed ID: 20515944
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy.
    Sayers TJ; Murphy WJ
    Cancer Immunol Immunother; 2006 Jan; 55(1):76-84. PubMed ID: 15864587
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity.
    Voltan R; Secchiero P; Casciano F; Milani D; Zauli G; Tisato V
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):364-374. PubMed ID: 27686849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TRAIL and apoptosis induction by TNF-family death receptors.
    Wang S; El-Deiry WS
    Oncogene; 2003 Nov; 22(53):8628-33. PubMed ID: 14634624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling.
    Peuhu E; Paul P; Remes M; Holmbom T; Eklund P; Sjöholm R; Eriksson JE
    Biochem Pharmacol; 2013 Sep; 86(5):571-83. PubMed ID: 23747345
    [TBL] [Abstract][Full Text] [Related]  

  • 67. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
    Kadowaki Y; Chari NS; Teo AE; Hashi A; Spurgers KB; McDonnell TJ
    Apoptosis; 2011 Jun; 16(6):627-35. PubMed ID: 21437722
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.
    Park S; Cho DH; Andera L; Suh N; Kim I
    Mol Cell Biochem; 2013 Nov; 383(1-2):39-48. PubMed ID: 23846485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ONC201: Stressing tumors to death.
    Endo Greer Y; Lipkowitz S
    Sci Signal; 2016 Feb; 9(415):fs1. PubMed ID: 26884598
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation.
    Henry CM; Martin SJ
    Mol Cell; 2017 Feb; 65(4):715-729.e5. PubMed ID: 28212752
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Bortezomib primes glioblastoma, including glioblastoma stem cells, for TRAIL by increasing tBid stability and mitochondrial apoptosis.
    Unterkircher T; Cristofanon S; Vellanki SH; Nonnenmacher L; Karpel-Massler G; Wirtz CR; Debatin KM; Fulda S
    Clin Cancer Res; 2011 Jun; 17(12):4019-30. PubMed ID: 21525171
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Auriculasin sensitizes primary prostate cancer cells to TRAIL-mediated apoptosis through up-regulation of the DR5-dependent pathway.
    Cho HD; Gu IA; Won YS; Moon KD; Park KH; Seo KI
    Food Chem Toxicol; 2019 Apr; 126():223-232. PubMed ID: 30817944
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases.
    Huang Y; Erdmann N; Peng H; Zhao Y; Zheng J
    Cell Mol Immunol; 2005 Apr; 2(2):113-22. PubMed ID: 16191417
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
    Platzbecker U; Kurre P; Guardiola P; Ward JL; Radich JP; Kiem HP; Deeg HJ
    Exp Hematol; 2004 Sep; 32(9):815-21. PubMed ID: 15345282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH; Bellail A; Tse MC; Yong VW; Hao C
    J Neurosci; 2006 Mar; 26(12):3299-308. PubMed ID: 16554480
    [TBL] [Abstract][Full Text] [Related]  

  • 77. TRAIL and NFkappaB signaling--a complex relationship.
    Wajant H
    Vitam Horm; 2004; 67():101-32. PubMed ID: 15110174
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hypoxia regulates TRAIL sensitivity of colorectal cancer cells through mitochondrial autophagy.
    Knoll G; Bittner S; Kurz M; Jantsch J; Ehrenschwender M
    Oncotarget; 2016 Jul; 7(27):41488-41504. PubMed ID: 27166192
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling.
    Kelley RF; Totpal K; Lindstrom SH; Mathieu M; Billeci K; Deforge L; Pai R; Hymowitz SG; Ashkenazi A
    J Biol Chem; 2005 Jan; 280(3):2205-12. PubMed ID: 15520016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ribosomal protein S6 is a selective mediator of TRAIL-apoptotic signaling.
    Jeon YJ; Kim IK; Hong SH; Nan H; Kim HJ; Lee HJ; Masuda ES; Meyuhas O; Oh BH; Jung YK
    Oncogene; 2008 Jul; 27(31):4344-52. PubMed ID: 18362888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.